Cargando…
Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct Disorders
OBJECTIVE: Therapeutic drug monitoring helps clinicians in choosing the right drug and adjust its dose in specific patients. To this end, we aimed to assess time patterns of risperidone and its metabolite, 9-hydroxyrisperidone, in children and adolescents with oppositional defiant and/or conduct dis...
Autores principales: | Piacentino, Daria, Kotzalidis, Georgios D., Schoretsanitis, Georgios, Paulzen, Michael, Haen, Ekkehard, Cappelletti, Simone, Giupponi, Giancarlo, Grözinger, Michael, Conca, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006987/ https://www.ncbi.nlm.nih.gov/pubmed/31958904 http://dx.doi.org/10.9758/cpn.2020.18.1.41 |
Ejemplares similares
-
Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia
por: Gaebler, Arnim Johannes, et al.
Publicado: (2023) -
Oppositional defiant disorder: current insight
por: Ghosh, Abhishek, et al.
Publicado: (2017) -
Pharmacotherapy for Hoarding Disorder: How did the Picture Change since its Excision from OCD?
por: Piacentino, Daria, et al.
Publicado: (2019) -
The Psychosocial Outcome of Conduct and Oppositional Defiant Disorder in Children With Attention Deficit Hyperactivity Disorder
por: Eskander, Noha
Publicado: (2020) -
Assessment of oppositional defiant disorder and oppositional behavior in children and adolescents with Down syndrome
por: Fucà, Elisa, et al.
Publicado: (2023)